Commentary · 31 Jan 2025
Conference abstractPublished 18 Sep 2020
SWOT analysis of Inhalers in Consideration of Sustainability and Lifecycle management
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Inhaled drug delivery has a long history in medicine and has revolutionised the treatment of respiratory diseases as well as presenting exciting opportunities for delivery of novel drug modalities, the anatomical features of the lung and surrounding circulation facilitating both local and systemic treatment. Inhaled drug products comprise the formulation and delivery system, for example, metered dose inhaler (MDI), dry powder inhaler (DPI) and nebulisers, with device selection being determined by patient need. The environmental impact of inhalers is an increasingly pertinent area for consideration. The global warming effect of propellants used in MDIs that led originally to the phase out of ozone-depleting chlorofluorocarbon propellants has again resurfaced due to the (albeit smaller) greenhouse effect of hydrofluoroalkane alternatives, leading to new research into “cleaner” replacements, for example, HFA152a (Noakes & Corr, 2016). . In addition, the Blue Planet effect is leading manufacturers to explore opportunities to improve sustainability of the plastics used in inhaler devices. Within this process, there are a number of factors that must be considered, to ensure seamless transition during product lifecycle evolution and minimise patient impact. This presentation intends to review the current situation, identify the opportunities and discuss some of the challenges that must be overcome in the lifecycle evolution of inhaled products in anticipation of future patient and environmental needs.
Keywords
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Chemical Biology & Pharmaceutical Chemistry.
Brief report · 31 Jan 2025
Chemical Biology Approaches to Modulate Protein–protein Interactions in Cancer Therapy
Opinion · 31 Jan 2025
Advances in Nanocarrier-based Drug Delivery: Bridging Chemistry and Pharmacology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Chemical Biology & Pharmaceutical Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Michelle L Dawson”
